Publications
Detailed Information
Reasonable Duration of Clopidogrel Use After Drug-Eluting Stent Implantation in Korean Patients
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Shin, Dong-Ho | - |
dc.contributor.author | Chae, In-Ho | - |
dc.contributor.author | Youn, Tae-Jin | - |
dc.contributor.author | Cho, Sung-Il | - |
dc.contributor.author | Suh, Jung-Won | - |
dc.contributor.author | Cho, Young-Seok | - |
dc.contributor.author | Choi, Young-Jin | - |
dc.contributor.author | Han, Kyoo-Rok | - |
dc.contributor.author | Choi, Dong-Ju | - |
dc.contributor.author | Gwon, Hyeon-Cheol | - |
dc.contributor.author | Chung, Woo-Young | - |
dc.contributor.author | Chang, Hyuk-Jae | - |
dc.contributor.author | Kwon, Dong-A | - |
dc.date.accessioned | 2012-05-22T08:33:13Z | - |
dc.date.available | 2012-05-22T08:33:13Z | - |
dc.date.issued | 2009-12-15 | - |
dc.identifier.citation | AMERICAN JOURNAL OF CARDIOLOGY; Vol.104 12; 1668-1673 | ko_KR |
dc.identifier.issn | 0002-9149 | - |
dc.identifier.uri | https://hdl.handle.net/10371/76254 | - |
dc.description.abstract | Current guidelines recommend that clopidogrel be given to patients for 12 months after drug-eluting stent (DES) implantation. However, the evidence is insufficient to support the benefit of long-term clopidogrel therapy, especially in Asian patients. The aim of this study was to evaluate whether different durations of clopidogrel use might influence long-term outcomes after DES implantation. A total of 844 patients from 4 medical centers in Korea who had undergone successful DES implantation from November 2004 to April 2006 were enrolled. Patients who were event free at 6-month follow-up were divided into 2 groups by clopidogrel use (575 users, 163 nonusers) and followed. The end point was a composite of death, myocardial infarction, and stent thrombosis. During 1,056.4 patient-years of follow-up (median 2.02), there were 7 deaths, 3 myocardial infarctions, and 2 episodes of stent thrombosis. No significant differences in the primary end point were observed between clopidogrel users and nonusers (cumulative incidence 2.9% vs 2.8%, p = 0.578; adjusted hazard ratio 0.67, 95% confidence interval 0.16 to 2.77). In analysis with time-dependent covariates, the incidence rates of the primary end point during observation periods with and without clopidogrel were similar, although the effect estimates were broad (9.9 with and 10.6 without clopidogrel per 1,000 patient-years; adjusted hazard ratio 0.52,95% confidence interval 0.09 to 3.17). Interestingly, the effect estimates from propensity score analyses, although they also had wide confidence intervals, were closer to the null than those from conventional Cox analyses. In conclusion, this cohort of Korean patients failed to show an absolute benefit of long-term clopidogrel therapy after DES implantation. The benefit of clopidogrel use beyond 6 months after DES implantation remains uncertain, and hence the decision to use long-term dual-antiplatelet therapy should be based on the risk factors of each patient. (C) 2009 Elsevier Inc. All rights reserved. (Am J Cardiol 2009;104:1668-1673) | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC | ko_KR |
dc.title | Reasonable Duration of Clopidogrel Use After Drug-Eluting Stent Implantation in Korean Patients | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 신동호 | - |
dc.contributor.AlternativeAuthor | 채인호 | - |
dc.contributor.AlternativeAuthor | 연태진 | - |
dc.contributor.AlternativeAuthor | 조성일 | - |
dc.contributor.AlternativeAuthor | 권동아 | - |
dc.contributor.AlternativeAuthor | 서정원 | - |
dc.contributor.AlternativeAuthor | 장혁재 | - |
dc.contributor.AlternativeAuthor | 조영석 | - |
dc.contributor.AlternativeAuthor | 정우영 | - |
dc.contributor.AlternativeAuthor | 최영진 | - |
dc.contributor.AlternativeAuthor | 권현철 | - |
dc.contributor.AlternativeAuthor | 한규록 | - |
dc.contributor.AlternativeAuthor | 최동주 | - |
dc.identifier.doi | 10.1016/j.amjcard.2009.07.049 | - |
dc.citation.journaltitle | AMERICAN JOURNAL OF CARDIOLOGY | - |
dc.description.citedreference | Kimura T, 2009, CIRCULATION, V119, P987, DOI 10.1161/CIRCULATIONAHA.108.808311 | - |
dc.description.citedreference | Cole SR, 2008, AM J EPIDEMIOL, V168, P656, DOI 10.1093/aje/kwn164 | - |
dc.description.citedreference | Brar SS, 2008, J AM COLL CARDIOL, V51, P2220, DOI 10.1016/j.jacc.2008.01.063 | - |
dc.description.citedreference | KING SB, 2008, J AM COLL CARDIOL, V51, P172 | - |
dc.description.citedreference | Curtis LH, 2007, MED CARE, V45, pS103 | - |
dc.description.citedreference | Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313 | - |
dc.description.citedreference | Eshaghian S, 2007, ANN INTERN MED, V146, P434 | - |
dc.description.citedreference | Lagerqvist B, 2007, NEW ENGL J MED, V356, P1009, DOI 10.1056/NEJMoa067722 | - |
dc.description.citedreference | Kastrati A, 2007, NEW ENGL J MED, V356, P1030, DOI 10.1056/NEJMoa067484 | - |
dc.description.citedreference | Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731 | - |
dc.description.citedreference | Spaulding C, 2007, NEW ENGL J MED, V356, P989, DOI 10.1056/NEJMoa066633 | - |
dc.description.citedreference | Eisenstein EL, 2007, JAMA-J AM MED ASSOC, V297, P159 | - |
dc.description.citedreference | HO PM, 2007, AM HEART J, V154, P846 | - |
dc.description.citedreference | Pfisterer M, 2006, J AM COLL CARDIOL, V48, P2584, DOI 10.1016/j.jacc.2006.10.026 | - |
dc.description.citedreference | Bhatt DL, 2006, NEW ENGL J MED, V354, P1706 | - |
dc.description.citedreference | Kuchulakanti PK, 2006, CIRCULATION, V113, P1108, DOI 10.1161/CIRCULATIONAHA.105.600155 | - |
dc.description.citedreference | Shishehbor MH, 2006, JAMA-J AM MED ASSOC, V295, P784, DOI 10.1001/jama.295.7.784 | - |
dc.description.citedreference | Kurth T, 2006, AM J EPIDEMIOL, V163, P262, DOI 10.1093/aje/kwj047 | - |
dc.description.citedreference | SMITH JC, 2006, J AM OLL CARDIOL, V47, pE1 | - |
dc.description.citedreference | Serruys PW, 2005, J AM COLL CARDIOL, V46, P575, DOI 10.1016/j.jacc.2004.12.082 | - |
dc.description.citedreference | Cole SR, 2004, COMPUT METH PROG BIO, V75, P45, DOI 10.1016/j.cmpb.2003.10.004 | - |
dc.description.citedreference | Sato T, 2003, EPIDEMIOLOGY, V14, P680, DOI 10.1097/01.EDE.0000081989.82616.7d | - |
dc.description.citedreference | Cepeda MS, 2003, AM J EPIDEMIOL, V158, P280, DOI 10.1093/aje/kwg115 | - |
dc.description.citedreference | Therneau TM, 2003, J COMPUT GRAPH STAT, V12, P156, DOI 10.1198/1061860031365 | - |
dc.description.citedreference | Braitman LE, 2002, ANN INTERN MED, V137, P693 | - |
dc.description.citedreference | Yusuf S, 2001, NEW ENGL J MED, V345, P494 | - |
dc.description.citedreference | Roux AVD, 2001, NEW ENGL J MED, V345, P99 | - |
dc.description.citedreference | Steyerberg EW, 2001, MED DECIS MAKING, V21, P45 | - |
dc.description.tc | 4 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.